These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32646876)

  • 21. Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI.
    Cicone F; Filss CP; Minniti G; Rossi-Espagnet C; Papa A; Scaringi C; Galldiks N; Bozzao A; Shah NJ; Scopinaro F; Langen KJ
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):905-15. PubMed ID: 25750084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A high
    Isal S; Gauchotte G; Rech F; Blonski M; Planel S; Chawki MB; Karcher G; Marie PY; Taillandier L; Verger A
    Br J Radiol; 2018 Apr; 91(1084):20170803. PubMed ID: 29271237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive differentiation of molecular subtypes of adult nonenhancing glioma using MRI perfusion and diffusion parameters.
    Pruis IJ; Koene SR; van der Voort SR; Incekara F; Vincent AJPE; van den Bent MJ; Lycklama À Nijeholt GJ; Nandoe Tewarie RDS; Veldhuijzen van Zanten SEM; Smits M
    Neurooncol Adv; 2022; 4(1):vdac023. PubMed ID: 35300151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies.
    Sadeghi N; D'Haene N; Decaestecker C; Levivier M; Metens T; Maris C; Wikler D; Baleriaux D; Salmon I; Goldman S
    AJNR Am J Neuroradiol; 2008 Mar; 29(3):476-82. PubMed ID: 18079184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.
    Fueger BJ; Czernin J; Cloughesy T; Silverman DH; Geist CL; Walter MA; Schiepers C; Nghiemphu P; Lai A; Phelps ME; Chen W
    J Nucl Med; 2010 Oct; 51(10):1532-8. PubMed ID: 20847166
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Zaragori T; Oster J; Roch V; Hossu G; Chawki MB; Grignon R; Pouget C; Gauchotte G; Rech F; Blonski M; Taillandier L; Imbert L; Verger A
    J Nucl Med; 2022 Jan; 63(1):147-157. PubMed ID: 34016731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The added value of apparent diffusion coefficient to cerebral blood volume in the preoperative grading of diffuse gliomas.
    Hilario A; Ramos A; Perez-Nuñez A; Salvador E; Millan JM; Lagares A; Sepulveda JM; Gonzalez-Leon P; Hernandez-Lain A; Ricoy JR
    AJNR Am J Neuroradiol; 2012 Apr; 33(4):701-7. PubMed ID: 22207304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET.
    Morana G; Piccardo A; Tortora D; Puntoni M; Severino M; Nozza P; Ravegnani M; Consales A; Mascelli S; Raso A; Cabria M; Verrico A; Milanaccio C; Rossi A
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2084-2093. PubMed ID: 28752225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis.
    Bekaert L; Valable S; Lechapt-Zalcman E; Ponte K; Collet S; Constans JM; Levallet G; Bordji K; Petit E; Branger P; Emery E; Manrique A; Barré L; Bernaudin M; Guillamo JS
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1383-1392. PubMed ID: 28315948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perfusion and diffusion MRI combined with ¹¹C-methionine PET in the preoperative evaluation of suspected adult low-grade gliomas.
    Berntsson SG; Falk A; Savitcheva I; Godau A; Zetterling M; Hesselager G; Alafuzoff I; Larsson EM; Smits A
    J Neurooncol; 2013 Sep; 114(2):241-9. PubMed ID: 23771511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. World Health Organization Grade II/III Glioma Molecular Status: Prediction by MRI Morphologic Features and Apparent Diffusion Coefficient.
    Maynard J; Okuchi S; Wastling S; Busaidi AA; Almossawi O; Mbatha W; Brandner S; Jaunmuktane Z; Koc AM; Mancini L; Jäger R; Thust S
    Radiology; 2020 Jul; 296(1):111-121. PubMed ID: 32315266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortical high-flow sign on arterial spin labeling: a novel biomarker for IDH-mutation and 1p/19q-codeletion status in diffuse gliomas without intense contrast enhancement.
    Yamashita K; Togao O; Kikuchi K; Kuga D; Sangatsuda Y; Fujioka Y; Kinoshita I; Obara M; Yoshimoto K; Ishigami K
    Neuroradiology; 2023 Sep; 65(9):1415-1418. PubMed ID: 37367991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study.
    Verburg N; Koopman T; Yaqub MM; Hoekstra OS; Lammertsma AA; Barkhof F; Pouwels PJW; Reijneveld JC; Heimans JJ; Rozemuller AJM; Bruynzeel AME; Lagerwaard F; Vandertop WP; Boellaard R; Wesseling P; de Witt Hamer PC
    Neuro Oncol; 2020 Mar; 22(3):412-422. PubMed ID: 31550353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors.
    Filss CP; Galldiks N; Stoffels G; Sabel M; Wittsack HJ; Turowski B; Antoch G; Zhang K; Fink GR; Coenen HH; Shah NJ; Herzog H; Langen KJ
    J Nucl Med; 2014 Apr; 55(4):540-5. PubMed ID: 24578243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of
    Zukotynski KA; Vajapeyam S; Fahey FH; Kocak M; Brown D; Ricci KI; Onar-Thomas A; Fouladi M; Poussaint TY
    J Nucl Med; 2017 Aug; 58(8):1264-1269. PubMed ID: 28360212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival Associations Using Perfusion and Diffusion Magnetic Resonance Imaging in Patients With Histologic and Genetic Defined Diffuse Glioma World Health Organization Grades II and III.
    Latysheva A; Emblem KE; Server A; Brandal P; Meling TR; Pahnke J; Hald JK
    J Comput Assist Tomogr; 2018; 42(5):807-815. PubMed ID: 29901512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intra-lesional spatial correlation of static and dynamic FET-PET parameters with MRI-based cerebral blood volume in patients with untreated glioma.
    Göttler J; Lukas M; Kluge A; Kaczmarz S; Gempt J; Ringel F; Mustafa M; Meyer B; Zimmer C; Schwaiger M; Förster S; Preibisch C; Pyka T
    Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):392-397. PubMed ID: 27913827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-invasive assessment of heterogeneity of gliomas using diffusion and perfusion MRI: correlation with spatially co-registered PET.
    Zhang Y; Lin Y; Xing Z; Yao S; Cao D; Miao WB
    Acta Radiol; 2022 May; 63(5):664-671. PubMed ID: 33858207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.
    Goyal A; Yolcu YU; Goyal A; Kerezoudis P; Brown DA; Graffeo CS; Goncalves S; Burns TC; Parney IF
    Neurosurg Focus; 2019 Dec; 47(6):E13. PubMed ID: 31786548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T2/FLAIR-mismatch sign for noninvasive detection of IDH-mutant 1p/19q non-codeleted gliomas: validity and pathophysiology.
    Foltyn M; Nieto Taborda KN; Neuberger U; Brugnara G; Reinhardt A; Stichel D; Heiland S; Herold-Mende C; Unterberg A; Debus J; von Deimling A; Wick W; Bendszus M; Kickingereder P
    Neurooncol Adv; 2020; 2(1):vdaa004. PubMed ID: 32642675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.